CNTF-secreting implant for dry AMD: Phase 2 trial in patients with geographic atrophy shows safety, potential therapeutic effect
Other
- Journal Article
Jaffe, GJ
Published in: Retina Today
October 1, 2009
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Retina Today
EISSN
1825-0572
Publication Date
October 1, 2009
Issue
OCTOBER
Start / End Page
52 / 53
Citation
APA
Chicago
ICMJE
MLA
NLM
Jaffe, G. J. (2009). CNTF-secreting implant for dry AMD: Phase 2 trial in patients with geographic atrophy shows safety, potential therapeutic effect. Retina Today.
Jaffe, G. J. “CNTF-secreting implant for dry AMD: Phase 2 trial in patients with geographic atrophy shows safety, potential therapeutic effect.” Retina Today, October 1, 2009.
Jaffe GJ. CNTF-secreting implant for dry AMD: Phase 2 trial in patients with geographic atrophy shows safety, potential therapeutic effect. Retina Today. 2009. p. 52–3.
Jaffe, G. J. “CNTF-secreting implant for dry AMD: Phase 2 trial in patients with geographic atrophy shows safety, potential therapeutic effect.” Retina Today, no. OCTOBER, 1 Oct. 2009, pp. 52–53.
Jaffe GJ. CNTF-secreting implant for dry AMD: Phase 2 trial in patients with geographic atrophy shows safety, potential therapeutic effect. Retina Today. 2009. p. 52–53.
Published In
Retina Today
EISSN
1825-0572
Publication Date
October 1, 2009
Issue
OCTOBER
Start / End Page
52 / 53